• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Treat NMD Logo (Copyright)

TREAT-NMD

Advancing diagnosis, care and treatment for people with neuromuscular diseases around the world

Contact us

header-right

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
  • What We Do
    • Advisory Committee for Therapeutics
    • The Global Registry Network
    • Core Datasets
    • Education
    • Post-Marketing Surveillance
  • Resources and Support
    • Neuromuscular Disease Information
    • Research Overview
    • Standards of Care & Family Guides
    • SOP Library
    • Social and Ethical Issues
  • Conference
    • Registration
    • Sponsorship Opportunities
    • Conference Programme
    • Sponsors of the TREAT-NMD 8th International Conference
    • Programme Committee
    • Abstracts
    • Venue
  • News & Events
    • News
    • TREAT-NMD Events
    • All Events
    • Submit an Event
    • Newsletter Sign-up
    • Contact Us

DMD dataset

Home / What We Do / Core Datasets / DMD dataset

The TREAT-NMD DMD core dataset project started in 2007-2008 and a revised version of the dataset was published in 2013. The dataset was expanded in February 2021 for clinically reported registries and in May 2021 for patient reported registries; this is the current version of the dataset (version 1.2).

The dataset is for all registries collecting data on individuals with DMD (clinician-, patient-, or dual-reported registries) with different mandatory items for different registry types. The DMD dataset can also be used to collect data from people living with Becker muscular dystrophy.

Current dataset

Version 1.2 of the DMD dataset has:

  • 112 unique data items
  • 73 mandatory items for clinician-reported registries
  • 48 mandatory items for patient-reported registries
  • 16 defined categories
  • Examples, data rules & tools

You can view Version 1.2 of the DMD core dataset on our web-based dataset specification tool.

Previous versions

Version 1 (2013) Dataset has:

  • 23 Data Items​
  • 14 mandatory items​
  • 9 Highly Encouraged Items​
  • 4 broad categories​

DMD 2013 can be found here: DMD Core Dataset May 2013

How the dataset was created

Version 1.0 of the TREAT-NMD DMD core dataset was published in 2013. The original DMD dataset was developed by expert consensus in 2007-2008 as part of the original TREAT-NMD FP6 EU project. This version of the DMD dataset was then revised in 2013 (as v1.0).

Version 1.2 of the dataset was published in 2021 after a 2-year process to reach consensus on the items collected. This dataset was published in February 2021 for clinician-reported registries and in May 2021 for patient-reported registries. The revised version was engineered to better inform on the natural history of DMD and provide data to support post-marketing surveillance (safety and effectiveness) for new treatments. The development of an expanded DMD dataset was the product of collaboration with Key Opinion Leaders, registry curators, regulators, and industry representatives. The draft dataset was reviewed by registries in a 4-month feasibility pilot, approved by the PI Michela Guglieri & TGDOC chairs. The dataset is also published in our Global Registries platform

Registries team/contacts

If you have further questions about the DMD dataset or any questions regarding the implementation, please contact the registries team.

Registry Team Members

Neil Bennett

Neil Bennett

Global Registries Manager

Neil is an experienced science communicator; in the neuromuscular disease area, he has worked at Act...

Annie Poll

Annie Poll

Research Communications Lead, TREAT-NMD

Annie trained in several academic research laboratories at Newcastle University before taking on pos...

Farjana Ali

Farjana Ali

Datasets and Global Registries Platform Coordinator

Primary Sidebar

  • What We Do
  • Advisory Committee for Therapeutics
    • Advisory Committee for Therapeutics
    • Members of the Advisory Committee for Therapeutics
    • Past Applicants
    • Advisory Committee for Therapeutics FAQs
  • Global Registry Network
    • The Global Registry Network
    • Global Data systems Oversight Committee – TGDOC
    • Members of the Registry Network
  • Core Datasets
    • Core Datasets
    • DM dataset
    • DMD dataset
    • FSHD dataset
    • LGMD dataset
    • SMA dataset
  • Education
    • Education
    • Masterclasses and Events
    • Sponsors of the TREAT-NMD 8th International Conference
    • Digital Resources
    • Endorsement of External Programmes
  • Post-Marketing Surveillance
    • Post-Marketing Surveillance
    • STRIDE Registry

Footer

Contact us

4th Floor
The Catalyst
Newcastle upon Tyne
NE4 5TG
United Kingdom
info@treat-nmd.com

Links

Home
Who we are
What we do
Who we support
Resources & support
Connect with us
Privacy Policy
Cookies

Newsletter Sign Up

Sign up to our monthly newsletter

 
ISO 27001 Accreditation Logo

Connect

info@treat-nmd.com
TREAT NMD © 2025
Privacy Policy
Sitemap
STCS LTD

  • Home
  • Who We Are
    • About Us
    • Partnerships and Collaborations
    • Governance
    • Our Team
  • Who We Support
    • Patients
    • Clinicians / Researchers
    • Life Sciences Industry
  • What We Do
    • Advisory Committee for Therapeutics
      • Members of the Advisory Committee for Therapeutics
      • Take Part in TACT
      • Past Applicants
    • The Global Registry Network
      • Members of the Registry Network
    • Core Datasets
      • DM dataset
      • DMD dataset
      • FSHD dataset
      • LGMD
      • SMA
    • Education
      • Masterclasses and Events
      • Digital Resources
      • Endorsement of External Programmes
    • Post-Marketing Surveillance
  • Resources and Support
    • Neuromuscular Disease Information
      • Becker muscular dystrophy
      • Charcot-Marie-Tooth
      • Congenital muscular dystrophy
      • Congenital myasthenic syndromes
      • Duchenne muscular dystrophy
      • Facioscapulohumeral muscular dystrophy
      • GNE myopathy
      • Limb girdle muscular dystrophy
      • Myotonic dystrophy
      • Myotubular and centronuclear myopathies
      • Spinal muscular atrophy
    • Research Overview
      • DMD
        • Gene Therapy for DMD
        • Mutation Specific Approaches
        • Cell Therapy
        • Drug Therapy
    • Standards of Care & Family Guides
      • CM Care
      • CMD Care
      • DM Care
      • DMD Care
      • BMD Care
      • FSHD Care
      • SMA Care
    • SOP Library
      • MDX Mouse (DMD)
      • GRMD Dog (DMD)
      • CMD Mouse (CMD)
      • SMA Mouse (SMA)
      • CMD animal models
      • MDC1A Preclinical Research
      • Cell Lines
        • Clinical Outcome Measures
        • Functional Evaluation Tools
        • NMR (MRI/MRS) Imaging
        • Muscle Biopsy
    • Social and Ethical Issues
  • Conference
    • Registration
    • Sponsorship Opportunities
    • Conference Programme
    • Sponsors of the TREAT-NMD 8th International Conference
    • Programme Committee
    • Abstracts
    • Venue
  • News & Events
    • News
    • TREAT-NMD Events
    • All Events
    • Submit an Event
    • Newsletter Sign-up
    • Contact Us